MSAM
CVS icon

Moloney Securities Asset Management’s CVS Health CVS Stock Holding History

Moloney Securities Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.67M Sell
22,206
-9,471
-30% -$649K 0.2% 121
2025
Q2 		$2.19M Sell
31,677
-1,161
-4% -$76.1K 0.27% 85
2025
Q1 		$2.22M Buy
32,838
+5,533
+20% +$331K 0.3% 77
2024
Q4 		$1.23M Buy
27,305
+708
+3% +$39.7K 0.16% 150
2024
Q3 		$1.67M Buy
26,597
+995
+4% +$58K 0.22% 114
2024
Q2 		$1.51M Buy
25,602
+7,662
+43% +$479K 0.22% 114
2024
Q1 		$1.43M Sell
17,940
-2,258
-11% -$172K 0.22% 117
2023
Q4 		$1.59M Sell
20,198
-555
-3% -$39.5K 0.25% 96
2023
Q3 		$1.45M Sell
20,753
-1,197
-5% -$84.8K 0.26% 94
2023
Q2 		$1.52M Buy
21,950
+2,692
+14% +$192K 0.27% 92
2023
Q1 		$1.43M Buy
19,258
+2,136
+12% +$179K 0.27% 98
2022
Q4 		$1.6M Sell
17,122
-6,674
-28% -$644K 0.35% 79
2022
Q3 		$2.27M Sell
23,796
-264
-1% -$26.1K 0.55% 48
2022
Q2 		$2.23M Buy
24,060
+8,026
+50% +$783K 0.52% 51
2022
Q1 		$1.62M Sell
16,034
-2,605
-14% -$274K 0.32% 86
2021
Q4 		$1.92M Buy
18,639
+496
+3% +$45.8K 0.33% 74
2021
Q3 		$1.54M Buy
18,143
+927
+5% +$77.6K 0.28% 97
2021
Q2 		$1.44M Buy
17,216
+573
+3% +$46.9K 0.26% 105
2021
Q1 		$1.25M Sell
16,643
-7,955
-32% -$579K 0.25% 108
2020
Q4 		$1.68M Sell
24,598
-861
-3% -$56K 0.37% 75
2020
Q3 		$1.49M Buy
25,459
+232
+0.9% +$14.4K 0.39% 77
2020
Q2 		$1.64M Sell
25,227
-149
-0.6% -$9.38K 0.48% 73
2020
Q1 		$1.51M Buy
25,376
+7,946
+46% +$530K 0.54% 61
2019
Q4 		$1.29M Sell
17,430
-1,324
-7% -$93K 0.4% 74
2019
Q3 		$1.18M Buy
+18,754
New +$1.11M 0.4% 73
2017
Q2 		– Sell
-3,029
Closed -$238K – 256
2017
Q1 		$238K Buy
+3,029
New +$242K 0.12% 203

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Moloney Securities Asset Management's CVS Position: Q3 2025 in Review

Moloney Securities Asset Management reduced its CVS Health (CVS) stake by 30% in Q3 2025, selling an estimated $649K and leaving 22,206 shares worth $1.67M. The position accounts for 0.2% of the portfolio, ranked #121.

Moloney Securities Asset Management first reported a position in CVS in Q1 2017 and has held it in 26 quarters since. The position peaked at $2.27M in Q3 2022. 1,834 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

  • Moloney Securities Asset Management held 22,206 shares of CVS Health worth $1.67M as of Q3 2025.
  • Moloney Securities Asset Management sold 9,471 CVS Health shares in Q3 2025, an estimated $649K.
  • CVS Health made up 0.2% of Moloney Securities Asset Management's portfolio in Q3 2025, its #121 holding.
  • Moloney Securities Asset Management first reported a position in CVS Health in Q1 2017 and has held it in 26 quarters since.
  • Moloney Securities Asset Management's CVS Health position peaked at $2.27M in Q3 2022.
  • 1,834 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Moloney Securities Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.